Lakshmi Krishnanunni: She holds M.Sc., M.Phil in Biochemistry and has strong proficiency in the areas of Immunology, Biomolecules, Cell biology, and Molecular biology to name a few. She has more than 10 years of Research experience in the field of medicinal plants research and Nanotechnology. Her expertise in research has greatly assisted in writing medical, health and research articles. As a writer, she aims to provide research-based information to the readers in more detail.
According to the American Journal of Managed Care (AJMC), the US Food and Drug Administration (USFDA) has approved Pexidartinib (Turalio) drug as first targeted therapy to treat symptomatic Tenosynovial Giant…
Continue Reading
ICYMI: FDA approves Pexidartinib (Turalio): A Drug for Rare Joint Tumor